Talks
Awiqli approved for T2D in children as young as 10
October 28, 2026
Share
SYNCHRONIZE-2: survodutide in T2D/obesity
October 28, 2026
Share
ACHIEVE-4 CV noninferiority with orforglipron
October 28, 2026
Share
Prediabetes and school breakfast participation
October 28, 2026
Share
GMI/A1c ratio, questions about discordance?
October 28, 2026
Share
Premature menopause, glycemic control and insulin resistance
October 28, 2026
Share
LibreDuo launch in the United States soon
October 28, 2026
Share
Triumph-2: retatrutide in T2D/obesity
October 28, 2026
Share
T2D remission with metabolic surgery
October 28, 2026
Share
ADA publishes "A Practical Guide to Hypoglycemia"
October 28, 2026
Share
Novo and Ascendis agreement for monthly GLP1RA ended
October 3, 2026
Share
AI facial screening for diabetes
October 3, 2026
Share
Foundayo versus oral Ozempic
October 3, 2026
Share
Approval of once weekly insulin Onswik
October 3, 2026
Share
Mounjaro CV label expansion
October 3, 2026
Share
Senseonics and Beta Bionics collaboration
October 3, 2026
Share
GLP1RA and respiratory flare-ups
October 3, 2026
Share
IcoSema study
October 3, 2026
Share
GLP1RAs and psychiatric adverse effects
October 3, 2026
Share
Early SGLT2i use in patients with T2D after AKI
October 3, 2026
Share
New AGA MASLD Guidelines: In T2D Proceed Directly to Imaging
August 1, 2026
Share
Machine Learning Models for Diabetes Classification
August 1, 2026
Share
Diabetes Onset & Vascular Dementia
August 1, 2026
Share
Metabolic Surgery in Adolescents with T2D
August 1, 2026
Share
GLP1RA & Smell/Taste Changes
August 1, 2026
Share
T2D Extended Visits
August 1, 2026
Share
GLP1RA Impact in T2D/PAD
August 1, 2026
Share
CGM Use by PCPs & its Impact
August 1, 2026
Share
CV Risk Prediction in T2D/MASLD
August 1, 2026
Share
Mortality Differences in T2D/ESRD & CGM
August 1, 2026
Share
Acanthosis & Sirolimus
July 29, 2026
Share
T2D & Hearing Loss
July 29, 2026
Share
Difficult to Control T2D & Hypercortisolism
July 29, 2026
Share
Glycemia & Brain Health
July 29, 2026
Share
GLP1RA Implant
July 29, 2026
Share
GLP1RA & Hair Loss in T2D
July 29, 2026
Share
Reinitiation of GLP1RA in Patients with T2D
July 29, 2026
Share
Gastric Emptying & Response to Tirzepatide
July 29, 2026
Share
Retatrutide Filing to FDA in Early 2027
July 29, 2026
Share
GLP1RA & Fracture Risk in T2D
July 29, 2026
Share
ADA 2026: Lp(a) & T2D Relationship?
June 15, 2026
Share
ADA 2026: Berobenatide VESPER-2 Trial
June 15, 2026
Share
ADA 2026: Retatrutide TRANSCEND-T2D-1 Trial
June 15, 2026
Share
ADA 2026: CagriSema REIMAGINE-3 Results
June 15, 2026
Share
ADA 2026: CagriSema REIMAGINE-2 Results
June 15, 2026
Share
ADA 2026: CagriSema REIMAGINE-1 Study Results
June 15, 2026
Share
ADA 2026: Retatrutide TRIUMPH-1 Trial
June 15, 2026
Share
ADA 2026: Zenagamtide
June 15, 2026
Share
ADA 2026: Elecoglipron VISTA Obesity Trial
June 15, 2026
Share
ADA 2026: Elecoglipron SOLSTICE Trial
June 15, 2026
Share
ADA 2026: Amylin Symposium
May 24, 2026
Share
ADA 2026: Amylin Symposium
May 24, 2026
Share
GLP-1RA Gene Therapy for T2D
May 24, 2026
Share
GLP-1RA Gene Therapy for T2D
May 24, 2026
Share
Hidden CGM Patterns & AI-Powered Algorithms to Predict T2D
May 24, 2026
Share
Hidden CGM Patterns & AI-Powered Algorithms to Predict T2D
May 24, 2026
Share
Continued High Rate of Death Due to Diabetes & Metabolic Conditions
May 24, 2026
Share
Continued High Rate of Death Due to Diabetes & Metabolic Conditions
May 24, 2026
Share
Tandem's First Tubeless Device
May 24, 2026
Share
Tandem's First Tubeless Device
May 24, 2026
Share
Loading logo
Close button
Why are you reporting this TALK?